Endovascular Thrombectomy

0

Pipeline Programs↗

2

Active Trials↗

0

Companies Involved↗

Endovascular Thrombectomy is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Completed3 · 50%

Recruiting2 · 33%

Unknown status1 · 17%

Clinical Trials

Trial Activity

6 trials

Outcome in Patients Treated With Endovascular Thrombectomy - optIMAL Blood Pressure Control 2 (OPTIMAL-BP 2)

Recruiting·YYonsei University·Phase 3·NCT06677970·176 enrolled

Intra-arterial Methylprednisolone After Successful Endovascular Thrombectomy Anterior Circulation Large Vessel Occlusion

Recruiting·TTang-Du Hospital·Phase 3·NCT07141303·1,060 enrolled

General Anesthesia for Endovascular Thrombectomy; A Pilot Study.

Completed·UUniversity of Saskatchewan·N/A·NCT02639806·34 enrolled

Intra-arterial TNK Following Endovascular Thrombectomy in Patients With Large Vessel Occlusion of Posterior Circulation

Completed·TThe First Affiliated Hospital of University of Science and Technology of China·Phase 2/3·NCT05684172·208 enrolled

MATRISS-II. Matrix Therapy to Reduce Ischemic Stroke Sequelae-II. A Randomized-double Blinded- Placebo Controlled Trial to Assess the Efficacy and Safety of OTR4132-MD in Patients With Acute Ischemic Stroke

Completed·OOrgan, Tissue, Regeneration, Repair and Replacement·Phase 2·NCT06700824·60 enrolled

Endovascular Thrombectomy With and Without Intravenous Thrombolysis in Extended Time Window

Unknown status·SSecond Affiliated Hospital, School of Medicine, Zhejiang University·Phase 3·NCT05634382·222 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)